The present study demonstrated that the deletion mutation in the dysbindin gene can augment both dopaminergic and serotonergic synaptic modulations in the hippocampus, suggesting that the dysbindin deficiency could be an essential genetic factor that leads to alterations in these neuromodulatory systems in schizophrenia. Here, DTNBP1 is linked to schizophrenia.